Klinik für Gyn. Endokrinologie und Reproduktionsmedizin der Frauenklinik des Universitätsspitals
Basel, 4031, Switzerland
NCT Number: NCT03398603
The developement of a new, stable measurement of the Antimuellerian Hormon (AMH) together with Roche Diagnostics International (Rotkreuz, CH) shall enable an automized and timely measurement of AMH values in blood samples.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Basel, 4031, Switzerland
An important requirement for the use of the new measurement to determine the AMH concentration is the stability of the AMH level over the menstrual cycle. So far the unbiased AMH concentration is the most important argument to manage this parameter.
There are several studies, which give different professional opinions of the AMH concentration depending on the phase of the menstrual cycle. Some authors came to the conclusion that the AMH concentration over the menstrual cycle is constant, others described significant fluctuations. It is unclear, if the described fluctuation is relevant for the interpretation of the ovarian reserve. Recently it could be shown, that intraindividual fluctuations of joung women during the menstrual cycle is stronger, which means that the measurement of AMH in this age is less secure.
The primary goal of the study is to evaluate, if the new AMH measurement with the ElecSys method delivers stable values over the menstrual cycle.
The secondary goal of the study is to determine whether there are any fluctuations in the number of antral follicles as given by 3D ultrasound.
For this reason we are recruiting a group of 50 women within two categories of age to measure eventually changes in AMH- concentration during their menstrual cycle.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
When included in the study blood samples and ultrasound are taken every second day of the first and third menstrual cycle after inclusion.
Time frame: 3 months
stabile assessment of ovarian reserve with AMH (pmol/l) in blood
Time frame: 3 months
Fluctuations of antral follicle count during different menstrual cycles
University Hospital, Basel, Switzerland
Other
Acronym: Bicycle
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04275700
Diminished Ovarian Reserve, Ovarian Failure
New York, United States
View Trial DetailsNCT06426771
AMH, Adnexal Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06394466
Endocrine System Diseases, Genital Diseases
Rio de Janeiro, Brazil
View Trial DetailsNCT04163640
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Basking Ridge, New Jersey, United States
View Trial Details